Online Inquiry
Inquiry
CP-690550 (Tofacitinib Citrate)
Product Name: | CP-690550 (Tofacitinib Citrate) |
CAT#: | DEJ-2312-LGZ-3 |
Package: | 10mg/50mg/100mg/10mM * 1mL in DMSO |
Datasheet |
Description
CP-690550 (Tofacitinib citrate) is a highly selective inhibitor of the Janus kinase (JAK) family of enzymes, and it is an orally available.
Basic Information
Synonyms: | CP690550; Tasocitinib Citrate; CP-690,550 |
Application: | JAK3 Inhibitor |
CAS Number: | 540737-29-9 |
Formula: | C16H20N6O.C6H8O7 |
Molecular Weight: | 504.5 |
SMILES: | C[C@@H]1CCN(C[C@@H]1N(C)C2=NC=NC3=C2C=CN3)C(=O)CC#N.C(C(=O)O)C(CC(=O)O)(C(=O)O)O |
Solubility-In vitro: | In vitro (25°C): DMSO: Warmed: 94 mg/mL (186.32 mM) Water: Insoluble Ethanol: Insoluble |
Solubility-In vivo: | 0.5% methylcellulose: 28 mg/mL |
Target Info
JAK3: IC50: | 1nM |
JAK2: IC50: | 20nM |
JAK1: IC50: | 112nM |
ROCK2: IC50: | 3.4μM |
LCK: IC50: | 3.87μM |
IRK: IC50: | >10μM |
CDK2: IC50: | >10μM |
CDK5: IC50: | >10μM |
EGFR: IC50: | >10μM |
MAPK2/ERK2: IC50: | >10μM |
JNK1/SAPK1c: IC50: | >10μM |
SAPK2a/p38: IC50: | >10μM |
SAPK2b/p38b2: IC50: | >10μM |
SAPK3/p38g: IC50: | >10μM |
SAPK4/p38d: IC50: | >10μM |
MAPKAPK2: IC50: | >10μM |
MAPKAP-K1b: IC50: | >10μM |
MSK1: IC50: | >10μM |
PRAK: IC50: | >10μM |
PKA: IC50: | >10μM |
PKCα: IC50: | >10μM |
PDK-1: IC50: | >10μM |
PKBα: IC50: | >10μM |
SGK: IC50: | >10μM |
p70S6K: IC50: | >10μM |
GSK-3β: IC50: | >10μM |
AMPK: IC50: | >10μM |
Chk1: IC50: | >10μM |
CK2: IC50: | >10μM |
PHK: IC50: | >10μM |
CSK: IC50: | >10μM |
CDK2/CyclinA: IC50: | >10μM |
PI3K: IC50: | >10μM |
Storage
|
Preparing Stock Solutions
0.1 mM_1 mg: 19.82 mL
0.1 mM_5 mg: 99.11 mL
0.1 mM_10 mg: 198.22 mL
0.5 mM_1 mg: 3.96 mL
0.5 mM_5 mg: 19.82 mL
0.5 mM_10 mg: 39.64 mL
1 mM_1 mg: 1.98 mL
1 mM_5 mg: 9.91 mL
1 mM_10 mg: 19.82 mL
5 mM_1 mg: 0.4 mL
5 mM_5 mg: 1.98 mL
5 mM_10 mg: 3.96 mL
|
All of our services and products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.